103 related articles for article (PubMed ID: 1917291)
1. Conformation of MeAla6-cyclosporin A by NMR. Relationship of sidechain orientation of the MeBmt-1, MeLeu-9, and MeLeu-10 residues to immunosuppressive activity.
Gooley PR; Durette PL; Boger J; Armitage IM
Int J Pept Protein Res; 1991 May; 37(5):351-63. PubMed ID: 1917291
[TBL] [Abstract][Full Text] [Related]
2. Modeling conformational changes in cyclosporin A.
O'Donohue MF; Burgess AW; Walkinshaw MD; Treutlein HR
Protein Sci; 1995 Oct; 4(10):2191-202. PubMed ID: 8535256
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporins: structure-activity relationships for the inhibition of the human FPR1 formylpeptide receptor.
Loor F; Tiberghien F; Wenandy T; Didier A; Traber R
J Med Chem; 2002 Oct; 45(21):4613-28. PubMed ID: 12361388
[TBL] [Abstract][Full Text] [Related]
4. The molecular replacement solution and X-ray refinement to 2.8 A of a decameric complex of human cyclophilin A with the immunosuppressive drug cyclosporin A.
Pflügl GM; Kallen J; Jansonius JN; Walkinshaw MD
J Mol Biol; 1994 Dec; 244(4):385-409. PubMed ID: 7990129
[TBL] [Abstract][Full Text] [Related]
5. Solution structure of the cyclosporin A/cyclophilin complex by NMR.
Thériault Y; Logan TM; Meadows R; Yu L; Olejniczak ET; Holzman TF; Simmer RL; Fesik SW
Nature; 1993 Jan; 361(6407):88-91. PubMed ID: 8421500
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporins from Mycelium sterilae MS 2929.
Kuzma M; Sedmera P; Jegorov A; Havlícek V
J Nat Prod; 2009 Jan; 72(1):159-63. PubMed ID: 19102681
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC transporter.
Loor F; Tiberghien F; Wenandy T; Didier A; Traber R
J Med Chem; 2002 Oct; 45(21):4598-612. PubMed ID: 12361387
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, conformation, and immunosuppressive activities of three analogues of cyclosporin A modified in the 1-position.
Aebi JD; Deyo DT; Sun CQ; Guillaume D; Dunlap B; Rich DH
J Med Chem; 1990 Mar; 33(3):999-1009. PubMed ID: 2308150
[TBL] [Abstract][Full Text] [Related]
9. Solution structure of cyclosporin A and a nonimmunosuppressive analog bound to fully deuterated cyclophilin.
Hsu VL; Armitage IM
Biochemistry; 1992 Dec; 31(51):12778-84. PubMed ID: 1463748
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological activity, and conformational analysis of (2S,3R,4S)-MeBmt1-cyclosporin, a novel 1-position epimer of cyclosporin A.
Rich DH; Sun CQ; Guillaume D; Dunlap B; Evans DA; Weber AE
J Med Chem; 1989 Aug; 32(8):1982-7. PubMed ID: 2754718
[TBL] [Abstract][Full Text] [Related]
11. The three-dimensional structure of a Plasmodium falciparum cyclophilin in complex with the potent anti-malarial cyclosporin A.
Peterson MR; Hall DR; Berriman M; Nunes JA; Leonard GA; Fairlamb AH; Hunter WN
J Mol Biol; 2000 Apr; 298(1):123-33. PubMed ID: 10756109
[TBL] [Abstract][Full Text] [Related]
12. Secondary structure of cyclosporine in a spray-dried liquid crystal by FTIR.
Stevenson CL; Tan MM; Lechuga-Ballesteros D
J Pharm Sci; 2003 Sep; 92(9):1832-43. PubMed ID: 12950001
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antimitogenic activities of four analogues of cyclosporin A modified in the 1-position.
Rich DH; Dhaon MK; Dunlap B; Miller SP
J Med Chem; 1986 Jun; 29(6):978-84. PubMed ID: 3712387
[TBL] [Abstract][Full Text] [Related]
14. A study of the correlation between cyclophilin binding and in vitro immunosuppressive activity of cyclosporine A and analogues.
Durette PL; Boger J; Dumont F; Firestone R; Frankshun RA; Koprak SL; Lin CS; Melino MR; Pessolano AA; Pisano J
Transplant Proc; 1988 Apr; 20(2 Suppl 2):51-7. PubMed ID: 2966482
[TBL] [Abstract][Full Text] [Related]
15. NMR studies of [U-13C]cyclosporin A bound to cyclophilin: bound conformation and portions of cyclosporin involved in binding.
Fesik SW; Gampe RT; Eaton HL; Gemmecker G; Olejniczak ET; Neri P; Holzman TF; Egan DA; Edalji R; Simmer R
Biochemistry; 1991 Jul; 30(26):6574-83. PubMed ID: 2054356
[TBL] [Abstract][Full Text] [Related]
16. Examination of structural characteristics of the potent oxytocin antagonists [dPen1,Pen6]-OT and [dPen1,Pen6, 5-tBuPro7]-OT by NMR, Raman, CD spectroscopy and molecular modeling.
Bélec L; Blankenship JW; Lubell WD
J Pept Sci; 2005 Jul; 11(7):365-78. PubMed ID: 15641022
[TBL] [Abstract][Full Text] [Related]
17. Conformational differences of an immunosuppressant peptolide in a single crystal and in a crystal complex with human cyclophilin A.
Mikol V; Taylor P; Kallen J; Walkinshaw MD
J Mol Biol; 1998 Oct; 283(2):451-61. PubMed ID: 9769217
[TBL] [Abstract][Full Text] [Related]
18. Effect of temperature on molecular structure of cyclosporin A.
Hasumi H; Nishikawa T; Ohtani H
Biochem Mol Biol Int; 1994 Oct; 34(3):505-11. PubMed ID: 7833828
[TBL] [Abstract][Full Text] [Related]
19. Role of amino acid N-methylation in cyclosporins on ring opening and fragmentation mechanisms during collisionally induced dissociation in an ion trap.
Kuzma M; Jegorov A; Hesso A; Tornaeus J; Sedmera P; Havlícek V
J Mass Spectrom; 2002 Mar; 37(3):292-8. PubMed ID: 11921370
[TBL] [Abstract][Full Text] [Related]
20. The NMR solution conformation of unligated human cyclophilin A.
Ottiger M; Zerbe O; Güntert P; Wüthrich K
J Mol Biol; 1997 Sep; 272(1):64-81. PubMed ID: 9299338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
